{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Restrict the search for
glutathione disulfide
to a specific field?
Status:
US Previously Marketed
Source:
Raptiva
(2003)
Source URL:
First approved in 2003
Source:
Raptiva
Source URL:
Class:
PROTEIN
Status:
US Previously Marketed
Source:
NATRECOR by SCIOS LLC
(2001)
Source URL:
First approved in 2001
Source:
NDA020920
Source URL:
Class:
PROTEIN
Conditions:
Nesiritide is the recombinant form of the 32 amino acid human B-type natriuretic peptide (BNP), which is normally produced by the ventricular myocardium. Human BNP binds to the particulate guanylate cyclase receptor of vascular smooth muscle and endothelial cells, leading to increased intracellular concentrations of guanosine 3'5'-cyclic monophosphate (cGMP) and smooth muscle cell relaxation. Cyclic GMP serves as a second messenger to dilate veins and arteries. Nesiritid was sold under brand name Natrecor for the intravenous treatment of patients with acutely decompensated congestive heart failure who have dyspnea at rest or with minimal activity.
Status:
US Previously Marketed
Source:
MYOSCINT by CENTOCOR INC
(1996)
Source URL:
First approved in 1996
Source:
MYOSCINT by CENTOCOR INC
Source URL:
Class:
PROTEIN
Status:
US Previously Marketed
Source:
DIAPID by NOVARTIS
(1970)
Source URL:
First approved in 1970
Source:
DIAPID by NOVARTIS
Source URL:
Class:
PROTEIN
Targets:
Conditions:
Lypressin is synthetic analog of porcine antidiuretic hormone vasopressin. Itis a cyclic nonapeptide that differs from Arg-vasopressin by one amino acid, containing Lys at residue 8 instead of Arg. Lypressin-containing nasal spray was used to treat diabetes insipidus, but its marketing by Sandoz (Novartis) was discontinued.
Status:
Possibly Marketed Outside US
Source:
pemgarda by Invivyd, Inc
(2024)
Source URL:
First approved in 2024
Source:
pemgarda by Invivyd, Inc
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
BLA125771
(2023)
Source URL:
First approved in 2023
Source:
BLA125771
Source URL:
Class:
PROTEIN
